Why Is CRISPR Genome-Editing Firm Caribou Biosciences Stock Trading Higher Today>

benzinga.com/news/fda/25/11/48596655/why-is-crispr-genome-editing-firm-caribou-biosciences-stock-trading-higher-today

Caribou Biosciences Inc. (NASDAQ:CRBU) stock surged on Monday. The company said the CAR-T therapy induced complete and durable remissions in patients with advanced B-cell lymphoma.
The CRISPR genome-editing biopharmaceutical company shared preliminary results from its ongoing ANTLER…

This story appeared on benzinga.com, 2025-11-03 16:48:45.
The Entire Business World on a Single Page. Free to Use →